Cutaneous Oncology News

Clinical gene expression profiling may be able to better identify melanoma patients who can safely forgo sentinel lymph node biopsy compared with current recommended conventions, according to a study.

Specific groups may experience less pain during anesthetic facial injections when a 34-gauge needle is used vs. a 33-gauge needle, according to a study.

Primary melanomas with incipient ulceration may be more aggressive than nonulcerated melanomas, thus warranting a higher-risk pathologic T stage, according to a study.

The Society for Immunotherapy of Cancer has issued an update to its melanoma clinical practice guideline.

Specialty training in dermatopathology correlated with a greater tendency to diagnose low risk melanomas as more severe, according to a study.

Positive results from a pivotal phase 2b trial showed mirdametinib significantly improved the outcomes of patients with neurofibromatosis type 1-associated plexiform neurofibromas, SpringWorks Therapeutics announced in a press release.

Patients with metastatic basal cell carcinoma experiencing distant organ involvement have worse outcomes than patients with nodal involvement, according to a study.

Cutaneous squamous cell carcinoma risk rises with every subsequent occurrence while the time interval decreases, according to a large cohort study.

Extensive perineural invasion may be the optimal prognostic measure of perineural invasion and poor cutaneous squamous cell carcinoma outcomes, according to a study.

CHICAGO — The skin and gut microbiome may be associated with developing or protecting against skin cancer as well as responding to cancer treatment, according to a speaker at the American Society for Dermatologic Surgery Annual Meeting.